Metformin Suppresses Both PD-L1 Expression in Cancer Cells and Cancer-Induced PD-1 Expression in Immune Cells to Promote Antitumor Immunity
Annals of Laboratory Medicine · 2024
DOI: 10.3343/alm.2023.0443 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Laboratory Medicine, 2024. Verfasst von Su Hwan Park und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, The Graduate School of Dong-A University, Busan, Korea. Hauptthemen laut MEDLINE: Metformin, Programmed Cell Death 1 Receptor, B7-H1 Antigen, Killer Cells, Natural. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Dong-A University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Sciences, The Graduate School of Dong-A University, Busan, Korea.
- Department of Medicinal Biotechnology, College of Health Science, Dong-A University, Busan, Korea.
- Department of Biomedical Sciences, Dong-A University, Busan, Korea.
ORCID-Profile: Su Hwan Park, Juheon Lee, Hye Jin Yun, Seok-Ho Kim, Jong-Ho Lee
Förderung
- Dong-A University
Zitieren
APA
Park, S. H., Lee, J., Yun, H. J., Kim, S. H., & Lee, J. H. (2024). Metformin Suppresses Both PD-L1 Expression in Cancer Cells and Cancer-Induced PD-1 Expression in Immune Cells to Promote Antitumor Immunity. Annals of Laboratory Medicine. https://doi.org/10.3343/alm.2023.0443
Vancouver
Park SH, Lee J, Yun HJ, Kim SH, Lee JH. Metformin Suppresses Both PD-L1 Expression in Cancer Cells and Cancer-Induced PD-1 Expression in Immune Cells to Promote Antitumor Immunity. Annals of Laboratory Medicine. 2024. doi:10.3343/alm.2023.0443
BibTeX
@article{Park2024,
author = {Park, Su Hwan and Lee, Juheon and Yun, Hye Jin and Kim, Seok-Ho and Lee, Jong-Ho},
title = {Metformin Suppresses Both PD-L1 Expression in Cancer Cells and Cancer-Induced PD-1 Expression in Immune Cells to Promote Antitumor Immunity},
journal = {Annals of Laboratory Medicine},
year = {2024},
doi = {10.3343/alm.2023.0443}
}
EUVIMED